Product name | Empagliflozin intermediate;Acetoxy empagliflozin; (1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol |
Synonyms | (1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl]oxy]phenyl] methyl]phenyl]-D-Glucitol;Acetoxy Empagliflozin; (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate; (1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol |
CAS No. | 915095-99-7 |
Molecular Formula | C31H35ClO11 |
Molecular Weight | 619.056 |
Molecular Structure | 
|
Quality Standard | 99% up by HPLC |
Appearance | White to off-white powder |
Acetoxy Empagliflozin Chemical Properties |
Boiling point | 673.8±55.0 °C(Predicted) |
density | 1.33±0.1 g/cm3(Predicted) |
Acetoxy Empagliflozin can be used as Empagliflozin intermediates and pharmaceutical intermediates, mainly used in laboratory research and development processes and chemical production processes.
Impurity of the Empagliflozin (E521510), from process for the preparation of glucopyranosyl-substituted benzonitriles for use as therapeutic agents treating metabolic disorders.
